News

2016 Emory University Compliance Program Manual

The number of laws, regulations and policies that impact the multitude of activities carried out at Emory University is enormous, and keeping up with these requirements can be challenging.  Although the Office of Compliance and the Internal Audit Division are separate units with distinct operational charges, both units recognize that a strong compliance program demonstrates the commitment of the University and its employees not only to the laws that govern our activities, but also to the ethical principles at the core of the University as an institute of higher education, research, and health care.  Accordingly, the Office of Compliance and the Internal Audit Division have collaborated on creation of the Emory University Compliance Program Manual as a means of providing faculty and staff members with an overview of the University’s compliance program.  
 
This publication provides faculty and staff members with information about some of the major policies and regulatory requirements that govern employee activities and introduces employees to the strong ethical principles that form the basis for Emory’s mission and work.  We hope this publication will serve both as a useful overview for new employees, and a handy reference guide for current faculty and staff.   
 
The manual is available here.


Emory's new Office of Compliance

To help Emory navigate the complex regulatory landscape, the offices of research and administrative compliance have been integrated into the Office of Compliance.  Kris West, J.D., M.S., has been named Emory’s first Chief Compliance Officer.




Follow us on Twitter:

Spotlight

New International Assessment Questionnaire

Global Services and the Office of Compliance worked together to create an assessment tool to assist the Office of Compliance in identifying activities that require additional assessment under export control and related regulations, and to enable Global Services to provide assistance with the various administrative and business considerations (e.g., HR, travel) that international projects can involve.  More information available here.

New tutorial

A new tutorial on the use of "Dangerous Drugs" in research is available.

New FDA financial disclosure form

The Office of Compliance has replaced the financial disclosure forms on our FDA regulated studies FAQ pages.  For more information continue reading here for a drug study and here for a device study

NOTE: The FDA financial disclosure form is different from and is in addition to any financial disclosure forms that are required by NIH.